Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II data presented for selatogrel in patients with acute myocardial infarction

Sep. 17, 2019

B cells, T cells honored as hybrids reported

Sep. 17, 2019

miR-744 found to be a prognostic factor in NSCLC

Sep. 17, 2019

YK-4-279 and TK-216 show promising preclinical activity in models of lymphoma

Sep. 17, 2019

Discovery of novel PS-targeting zinc dipicolylamine-based drug conjugates

Sep. 17, 2019

Preliminary clinical data presented from U.S. phase II study of ANAVEX 2-73 in Rett syndrome

Sep. 17, 2019

Precision BioSciences announces FDA clearance of IND for PBCAR-20-A

Sep. 17, 2019

First patient dosed in phase I study of KO-539 for AML

Sep. 17, 2019

Getting to the root of schizophrenia

Sep. 17, 2019

Nitazoxanide amplifies RNA sensor and type I interferon activities and inhibits Ebola virus

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...